Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial-Reference-Cited by-同舟云学术

Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial

Published:2021-07 Issue: Volume:334 Page:37-41
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Iglesias Juan F.,Muller Olivier,Losdat Sylvain,Roffi Marco,Kurz David J.,Weilenmann Daniel,Kaiser Christoph,Heg Dik,Valgimigli Marco,Windecker Stephan,Pilgrim Thomas

Funder

BIOTRONIK SE und Co KG

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference11 articles.

1. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction;Park;JAMA,2014

2. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction;Sorajja;Eur. Heart J.,2007

3. Complete revascularization with multivessel PCI for myocardial infarction;Mehta;N. Engl. J. Med.,2019

4. Long-term follow-up of complete versus lesion-only revascularization in STEMI and multivessel disease: the CvLPRIT trial;Gershlick;J. Am. Coll. Cardiol.,2019

5. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial;Iglesias;Lancet,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trials using composite outcomes neglect the presence of competing risks: a methodological survey of cardiovascular studies;Journal of Clinical Epidemiology;2023-08

2. Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome;Clinical Interventions in Aging;2021-08